Europe Recommends Three Cancer Drugs
The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Stay updated with breaking news from Dvanced Bc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.
Adapting chemo-free maintenance strategies in TNBC could offer effective disease control while improving patients' quality of life.
Patients with breast cancer might be eligible to enroll in one of these clinical trials.
Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.